razoxane has been researched along with Arrhythmias, Cardiac in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balis, FM; Ginsberg, JP; Sepe, DM | 1 |
| Boudíková, A; Dabrowská, L; Geršl, V; Kolář, F; Mandíková, P; Mikšík, I; Mráz, J; Neckář, J; Popelová, O; Stěrba, M | 1 |
| Carpi, A; Cecconi, N; Cervetti, G; Franzoni, F; Galetta, F; Petrini, M; Santoro, G | 1 |
| Bernadic, M; Foltinová, A; Hulín, I; Mladosievicova, B; Petrásová, H | 1 |
2 trial(s) available for razoxane and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.
Topics: Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Cardiovascular Agents; Drug Therapy, Combination; Electrocardiography; Epirubicin; Female; Heart Conduction System; Humans; Lymphoma, Non-Hodgkin; Male; Razoxane; Time Factors | 2005 |
Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane.
Topics: Adolescent; Antineoplastic Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiovascular Agents; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Electrocardiography; Female; Fourier Analysis; Hodgkin Disease; Humans; Infant; Male; Razoxane | 2001 |
2 other study(ies) available for razoxane and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Dexrazoxane as a cardioprotectant in children receiving anthracyclines.
Topics: Adolescent; Anthracyclines; Antineoplastic Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotonic Agents; Child; Child, Preschool; Heart Failure; Humans; Razoxane; Risk Factors; Treatment Outcome; Young Adult | 2010 |
Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Razoxane; Reactive Oxygen Species; Treatment Outcome | 2012 |